Local Institution - 2107 — Nashville, Tennessee

Local Institution - 2107 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 2107 has participated in 1 clinical trials.

Therapeutic areas: Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, NSCLC.

Sponsors: Turning Point Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 2107?

Local Institution - 2107 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 2107 conducted?

Local Institution - 2107 has 1 clinical trials on record. Their work covers Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, NSCLC.

Is Local Institution - 2107 accredited by Crixeo Clinical Trials?

Local Institution - 2107 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 2107?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.